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Available online 29 April 2008The BTas protein of bovine foamy virus (BFV) is a 249-amino-acid nuclear regulatory protein which
transactivates viral gene expression directed by the long terminal repeat promoter (LTR) and the internal
promoter (IP). Here, we demonstrate the BTas protein forms a dimeric complex in mammalian cells by using
mammalian two hybrid systems and cross-linking assay. Functional analyses with deletion mutants reveal
that the region of 46–62aa is essential for dimer formation. Furthermore, our results show that deleting the
dimerization region of BTas did not affect the localization of BTas, but that it did result in the loss of its
transactivational activity on the LTR and IP. Furthermore, BTas (Δ46–62aa) retained binding ability to the LTR
and IP similar to that of the wild-type BTas. These data suggest the dimerization region is necessary for the
transactivational function of BTas and is crucial to the replication of BFV.
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Foamy viruses (FVs), also known as spumaretroviruses, are
complex retroviruses which compose the only genus in the Spumar-
etrovirinae subfamily of Retroviridae. The gene expression of FVs is
strictly dependent on the transactivator protein called Tas. In contrast
to other complex retroviruses (Cullen, 1991), FVs uniquely harbors an
internal promoter (IP) in addition to the conventional long terminal
repeat promoter (LTR) (Linial, 1999). The transcriptional activities of
both promoters strictly depend on the viral transactivator. The IP has
been suggested to form a positive feedback loop for viral gene
expression in which the basal activity of the IP is increased by its own
gene product (LÖchelt et al., 1993). The nuclear Tas protein of the
primate prototype FV (PFV) binds DNA target sites directly and
consists of at least two functional domains, an N-terminal/central DNA
binding and a C-terminal activation domain (Garrett et al., 1993; He
et al., 1996, 1993; Kang et al., 1998).
Bovine foamyvirus (BFV) is theﬁrstnon-primate FV thatwas isolated
in 1983 (Johnson et al., 1983). Studies of BFV in their natural hosts
indicate that antiviral antibodies, but not viral infections, are acquired
maternally. Animals become infected as young adults, presumably via
saliva (Kertayadnya et al., 1988). As experimental infection by BFV
caused no clinical signs in cattle, BFV has been considered to be non-
pathogenic (Johnson et al., 1988; Kertayadnya et al., 1988). The genome
of BFV contains three open reading frames (ORFs) encoding the Gag, Pol
and Env structural proteins; the regulatory borf1 (or btas) and borf2.
l rights reserved.genes are located between the env gene and the 3′ LTR, which are under
the control of both the 5′ LTR and an IP (Holzschu et al., 1998). The btas
gene encodes a 249-amino-acid regulatory protein termed BTas. The
transactivator protein (BTas) of BFV acts as the key regulator of viral
replication and gene expression. BTas is a DNA-binding protein that can
transactivate both the LTR and the IP promoter by speciﬁcally binding to
the transactivation responsive element (TRE) (Liu et al., 1999; Zhang et
al., 2000). Although BTas does not have a conserved nuclear localization
signal (NLS), it accumulates predominantly in the nucleus.
BFV has a genomic organization similar to that of the PFV. The PFV
Tas protein forms a multimeric complex in the nuclei of mammalian
cells, though whether oligomerization of Tas is important for the
transactivation activity is unknown (Chang et al., 1995). To investigate
whether the BTas protein functions as a monomer or an oligomer, we
used an in vivo assay of protein–protein interaction. Our results show
that the BTas protein forms a homodimer in mammalian cells, and the
region for this speciﬁc dimerization is mapped to residues 46 to 62.
Furthermore, we ﬁnd that this dimerization region is important for
the transactivating activity of BTas. Thus, we conclude that BTas
functions as a homodimer in the replication of BFV.
Results
The BTas protein forms dimeric complexes in vivo and in vitro
Previously, it was reported that several transactivators of human
retroviruses could form multimeric complexes in the nuclei of
eukaryotic cells. These transactivators include the Tat and Rev proteins
of thehuman immunodeﬁciency virus type-1 (HIV-1), the Rex protein of
the human T-lymphotrophic virus (HTLV-1) and the Tas protein of PFV
Fig. 1. The BTas protein forms multimeric complexes in vivo and in vitro. (A) 293T cells
were transfected with Myc-BTas and Flag-BTas as indicated. Flag-BTas was immuno-
precipitated and immunoblotted with the indicated antibodies. (B) 293T cells were
transfected with Myc-BTas and Flag-BTas as indicated. Myc-BTas was immunoprecipi-
tated and immunoblotted with the indicated antibodies. (C) Puriﬁed His-BTas was
incubated with GST-BTas or GST immobilized on sepharose beads. GST-pulldown was
then performed, and the presence of His-BTas in the pulldownpreparationwas detected
by Western blotting using an anti-His antibody. Puriﬁed GST-BTas and GST used in the
pulldown assay were detected by Coomassie blue staining.
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al., 1991). To test whether BTas interacts with itself in vivo, 293T cells
were co-transfectedwith two differentially tagged BTas constructs (Flag
epitope-tagged BTas and Myc epitope-tagged BTas). Proteins immuno-
precipitated by an anti-Flag antibody were resolved by SDS-PAGE and
analyzed byWestern blotting using an anti-Myc antibody. Fig.1A showsFig. 2. The BTas protein forms dimeric complexes in mammalian cells. (A) 293T cells
transiently expressing Flag-BTas or the empty vector were incubated with or without
the cross-linking buffer. Cell lysates were analyzed byWestern blotting. The positions of
Flag-BTas monomers (M) and dimmer (D) are indicated. (B) pCMV-BD-BTas (1–183aa)
and pCMV-AD-BTas were transfected into 293T cells along with Gal4-Luc reporter gene
as indicated. Forty-eight hours after transfection, luciferase activities were measured as
described in Materials and methods.the binding of Myc-BTas to Flag-BTas. Similar results were observed
when the sampleswere immunoprecipitatedwithananti-Myc antibody
and analyzed by an anti-Flag antibody (Fig. 1B). From these results, we
concluded that BTas indeed interacted with itself in mammalian cells.
In vitro GST-pulldown assay was then performed to investigate
whether the formation of BTas multimeric complexes is direct.
Puriﬁed GST-BTas or GST was immobilized on glutathione sepharose
beads and incubated with puriﬁed His-BTas. In this experiment, GST-
BTas bound to His-BTas, indicating a direct interaction (Fig. 1C).
Together, these results suggest that BTas can form multimeric com-
plexes in vivo and in vitro.
To substantiate the ﬁnding of the dimeric form of BTas in vivo, we
transiently expressed BTas in 293T cells and chemically cross-linked
the proteins. As shown in Fig. 2A, a product with an apparent
molecular mass of 80 kDa was detected by Western blot assay,
suggesting that BTas could exist as homodimers.
In addition, a mammalian two hybrid system was used to further
investigate the BTas self-interaction inmammalian cells by using aGal4-
Luc reporter gene. We found only marginal luciferase activity when co-Fig. 3. Identiﬁcation of the region required for BTas homodimer formation. (A) Schematic
representation of BTas and deletion mutants. (B and C) 293T cells were transiently
transfected with Myc-BTas together with the indicated Flag-BTas wild-type or
truncation mutants. The Flag-tagged proteins were immunoprecipitated and immuno-
blotted with the indicated antibodies. (D) 293T cells transiently expressing Flag-BTas,
Flag-BTas (Δ46–62aa) or the empty vector were incubated with or without the cross-
linking buffer. Cell lysates were analyzed byWestern blotting. The positions of Flag-BTas
monomers (M) and dimmer (D) are indicated.
Fig. 4. The localization of BTas does not require homodimerization. Indirect
immunoﬂuorescence was used to localize BTas or BTas (Δ46–62aa) (mouse anti-BTas
antibody and FITC-conjugated rabbit anti-mouse secondary antibody). Nuclei were
visualized using DAPI stain. (A) Individual expression of BTas in HeLa cells. (B) Individual
expression of BTas (Δ46–62aa) in HeLa cells.
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reporter gene. In contrast, robust luciferase activity was detected when
293T cells were co-transfected with Gal4-BD-BTas (1–183aa), Gal4-AD-
BTas and the Gal4-Luc reporter gene. Notably, the induced luciferase
activity was signiﬁcantly increased in a Gal4-AD-BTas dose-dependent
manner, whereas Gal4-AD-BTas alone did not display any effect on the
Gal4-Luc reporter gene (Fig. 2B). These results are indicative that the
BTas protein forms homodimers in mammalian cells.
Identiﬁcation of the region required for BTas homodimer formation
To identify the sequences required for the dimerization of BTas, we
created ﬁne deletionmutants, as depicted in Fig. 3A tagged with a Flag
epitope. 293T Cells were co-transfected with each mutant together
with Myc-BTas and protein dimerization was analyzed by co-
immunoprecipitation assays. As shown in Fig. 3B, all the C-terminal
truncation mutants, including Flag-BTas (1–183aa) and Flag-BTas (1–
133aa), retain the ability to bind toMyc-BTas. These results suggest the
dimerization region of BTas is not located in the activation domain
(184–249aa). The dimerization region was determined to comprise
amino acids 46–62, since Flag-BTas (67–249aa), Flag-BTas (90–249aa)Fig. 5. DNA binding of BTas does not require homodimerization. (A) EMSAwas performed wi
LTR.TRE were used as the probe. (B) EMSAwas performed with puriﬁed GST, BTas or BTas (Δ
(C) Puriﬁed GST, BTas and BTas (Δ46–62aa) used in EMSA were detected by Coomassie blueand Flag-BTas (Δ46–62aa) could not bind toMyc-BTas, while Flag-BTas
(27–249aa) and Flag-BTas (35–249aa) held the binding ability (Fig. 3C).
To further test the requirement of the N-terminal domain for BTas
homodimer formation in vivo, we transiently expressed Flag-BTas or
Flag-BTas (Δ46–62aa) in 293T cells and performed a chemical cross-
linking assay. As shown in Fig. 3D, Flag-BTas can form homodimers
while Flag-BTas (Δ46–62aa) could not. This result further conﬁrms
that the 46–62aa region of BTas is critical for its homodimerization.
The localization of BTas does not require homodimerization
BTas is required for the replication of BFV and can only exert its
transactivation function in the nucleus. Therefore, we wanted to know
whether only the homodimeric BTas could enter the nucleus. To test
this assumption, HeLa cells were transfectedwith BTas and BTas (Δ46–
62aa) vectors encoding plasmids, and indirect immunoﬂuorescence
staining was used to localize the expressed proteins 48 h after
transfection. Both the wild-type BTas (Fig. 4A) and BTas (Δ46–62aa)
(Fig. 4B) were predominantly located in the nucleus. This result
suggests that the formation of homodimers is not a necessary
prerequisite for nuclear entry.
DNA binding of BTas does not require homodimerization
BTas is a DNA-binding protein that can transactivate both the LTR
and the IP by speciﬁcally binding to the TRE. To determinewhether the
formation of homodimers is necessary for BTas to bind to the LTR.TRE
and the IP.TRE, electrophoretic mobility shift assays (EMSA) were
performed. Both puriﬁed BTas (Δ46–62aa) and BTas proteins could
bind to the LTR.TRE (Fig. 5A, lanes 2, 4) and the IP.TRE (Fig. 5B, lanes 2,
4), and the complexes could be removed by competing with the
unlabeled LTR.TRE (Fig. 5A, lanes 3, 5) and IP.TRE (Fig. 5B, lanes 3, 5). As
a negative control, puriﬁed GST protein could not bind to the LTR.TRE
(Fig. 5A, lane 1) and the IP.TRE (Fig. 5B, lane 1). Puriﬁed GST, BTas and
BTas (Δ46–62aa) used in the EMSA were detected by Coomassie blue
staining (Fig. 5C). This result suggests that the formation of
homodimers is not necessary for the DNA-binding activity of BTas.
BTas-mediated transcriptional activations require homodimerization
Although deletion of the dimeric region does not affect the
localization and the binding activity of BTas, deletion of the dimeric
region may affect the transcriptional activation of BTas. To determineth puriﬁed GST, BTas or BTas (Δ46–62aa). Digitonin-labeled sequences derived from BFV
46–62aa). Digitonin-labeled sequences derived from BFV IP.TRE were used as the probe.
staining.
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and IP, a luciferase reporter gene under the transcriptional control of the
BFV LTR (LTR-luc) or IP (IP-luc) was used in the transactivation assays.
293T cells were transfected with the BFV LTR-luc or IP-luc in the
presence of BTas, BTas (Δ46–62aa) or the empty vector. Luciferase
activities were measured 48 h later. Compared with control cells, BTas
can remarkably transactivate the BFV LTR and IP, but removal of the
homodimeric region of BTas resulted in a disappearance in BTas-
induced transactivation (Fig. 6A). Similar results were also observed in
HeLa cells (Fig. 6B).
Because BTas also can stimulate the NF-κB pathway in HeLa cells,
we tested whether deletion of the dimeric region could affect the
activity of the NF-κB pathway. HeLa cells were transfected with NF-κB
(3×)-luc in the presence of BTas, BTas (Δ46–62aa) or the empty vector.Fig. 6. BTas-mediated transcriptional activations require homodimerization. (A) 293T
cells were transfected with the BFV LTR-luc or IP-luc in the presence of BTas, BTas (Δ46–
62aa) or the empty vector. Luciferase activities were measured 48 h later. (B) HeLa cells
were transfectedwith the BFV LTR-luc or IP-luc in the presence of BTas, BTas (Δ46–62aa)
or the empty vector. Luciferase activities were measured 48 h later. (C) HeLa cells were
transfected with the NF-κB (3×)-luc in the presence of BTas, BTas (Δ46–62aa) or the
empty vector. Luciferase activities were measured 48 h later. All transfections were
performed in triplicate.Similar to the results of LTR-luc and IP-luc, stimulating the NF-κB
pathway also required homodimerized BTas (Fig. 6C). These results
suggest that the formation of BTas homodimers is necessary for BTas-
induced transcriptional activation.
Discussion
Although the importance of BTas in the transactivation of BFV LTR
and IP and the replication of BFV is well established, the mechanisms
underlying its function and how its activity is regulated remain
unknown. Functional analyses of a series of deletions of the BTas
protein revealed the presence of at least two major functional
domains that include an N-terminal binding domain (1–133aa) and
a C-terminal activation domain (184–249aa) (data not shown). Based
upon results of co-immunoprecipitation and chemical cross-linking of
BTas complexes, we suggest that BTas is a stable dimer. The results of
themammalian two hybrid assay also provided evidence that BTas can
form homodimers in mammalian cells. We also established a positive
correlation between homodimerization and the gene expression of
BFV. Thus, BTas appears to function in a homodimer form. Although
residues 46 to 62 in BTas do not contain a special motif, our data
suggested strongly that this region is responsible for the homodimer
formation of BTas.
Many eukaryotic transcription factors take the form of dimers or
higher-order multimers as an absolute requirement for biological
activity (Bogerd et al., 1993; Chen et al., 1992; Hu et al., 1990;
Landschulz et al., 1988; McIntyre et al., 1993;Williams and Tjian,1991;
Xia and Lai, 1992; Zapp et al., 1991). Structural domains or motifs
mediating speciﬁc interactions have been characterized, such as the
leucine zipper, helix–loop–helix, and helix–span–helix proteins
(Jones, 1990; Lamb and McKnight, 1991; Landschulz et al., 1988). In
addition, several proteins, such as E7, Tat and Rex, possess only one
dimerization domain (Bogerd and Greene, 1993; Frankel et al., 1988;
McIntyre et al., 1993). However, other proteins, such as Myc, E12 and
AP4, possess more than one dimerization domain (Hu et al., 1990;
Kerkhoff and Bister, 1991; Lamb and McKnight, 1991). In contrast to
BTas, Tas of PFV has three domains whichmediatemultimer formation
(Chang et al., 1995). The comparison of the multimerization domains
of both proteins did not reveal obvious homologies. Furthermore, the
biological function of Tas multimerization has not been deﬁned
(Chang et al., 1995). Here, we report the role of dimerization of BTas in
the replication of BFV.
Dimerization of transcription factors and activators is a common
phenomenon associated with gene transcription. For instance, tran-
scriptional factors in the AP-1 family form homodimers or hetero-
dimers that are crucial for transcriptional activation. By exploiting such
properties, we generated dominant BTas deletions that block its
transcriptional activities in 293T and HeLa cells. Although the deletion
of residues 46 to 62 failed to affect the localization and the binding
activity of BTas, it had a dramatic effect on BTas function. Deleting the
dimeric region abolished the BTas-induced transactivation of BFV LTR
and IP, suggesting that unique interactions of the dimeric region are
involved in inducing the conformational change. Our ﬁndings also
suggest that BTas is in a homodimeric conﬁguration for activation of
the NF-κB pathway because BTas (Δ46–62aa) which cannot form
dimers failed to activate the NF-κB pathway. The experiments
presented in this article provide biochemical and genetic evidence
that the active form of BTas is a dimer.
Another intriguing aspect of our current ﬁnding is that nonfunc-
tional monomeric BTas and functional dimeric BTas have similar
abilities to bind to the BFV LTR and the IP. However, we did not address
the question on cellular proteins interacting with the Tas activation
domains which may be essential for mediating viral transcription. In
this respect, our ﬁndings are consistent with the possibility that the
deletionmutants (Δ46–62aa) of BTas bind as nonfunctionalmonomers
to the target DNA sequences in vivo, but are incapable of undergoing
240 J. Tan et al. / Virology 376 (2008) 236–241either a prior or subsequent protein assembly reaction required for
their biological function.
In this paper, we demonstrated that the biological function of BTas
critically involves the recruitment of dimeric BTas molecules to the
DNA response elements in vivo. It is possible that these protein–
protein interactions of fully assembled dimeric BTas on the DNA
response elements are essential for further interactions with cellular
cofactors needed for BTas function.
Materials and methods
Plasmids
BFV pCMV-BTas, pLTR-luc and pIP-luc were constructed as
described previously (Liu et al., 1999; Zhang et al., 2000). The
pCMV-Tag2B-BTas, pCMV-Tag2B-BTas (1–133aa), pCMV-Tag2B-BTas
(1–183aa), pCMV-Tag2B-BTas (27–249aa), pCMV-Tag2B-BTas (35–
249aa), pCMV-Tag2B-BTas (67–249aa), pCMV-Tag2B-BTas (90–
249aa) and pCMV-Tag2B-BTas (Δ46–62aa) were constructed by
inserting individual PCR fragment into the pCMV-Tag2B vector
(Stratagene). The pCMV-BTas (Δ46–62aa) and pCMV-Tag3B-BTas
were subcloned into the pcDNA3.1 (+) (Invitrogen) or pCMV-Tag3B
(Stratagene) vector, respectively. pCMV-BD-BTas (1–183aa) and
pCMV-AD-BTas were subcloned into the pCMV-BD (Clontech) or
pCMV-AD (Clontech) vector, respectively. All the new constructs were
conﬁrmed by sequencing.
Antibodies and immunoprecipitation
Anti-FLAG M2 mAb and anti-Myc rAb were purchased from Santa
Cruz Biotechnology (Santa Cruz, CA). The antibody to BTas was
produced by the immunization of mice and puriﬁed according to a
standard protocol. Protein A bead was purchased from Sigma-Aldrich.
293Tcells were transfectedwith plasmids using polyethylenimines
(PEI) according to the manufacturer's protocol (Durocher, Perret, and
Kamen, 2002). After 48 h following transfection, the cells were lysed
in 1 ml lysis buffer (50 mM Tris–HCl, 150 mM NaCl, pH 8.0, 1% NP-40,
0.2% SDS and 1 mM phenylmethylsulfonyl ﬂuoride), sonicated and
centrifuged at 4 °C (10,000 g, 15 min). The supernatant (500 μl) was
incubated with the indicated antibody at 4 °C for 2 h. The protein
A-Sepharose (50%, 25 μl) equilibrated in lysis buffer was then added
and incubated for an additional 2 h. Immunocomplexes were washed
ﬁve times with the lysis buffer, boiled in 35 μl of 1× Laemmli buffer,
electrophoresed on 12% SDS polyacrylamide gels, and processed by
Western blotting.
GST-pulldown assay
For GST-pulldown in vitro, GST or GST-BTas fusion protein
immobilized on glutathione sepharose beads (Amersham Biosciences)
was incubated with puriﬁed His-BTas protein at 4 °C for 2 h in 20 mM
Tris, pH 8.0, 100 mM NaCl, 5 mMMgCl2, 0.5% Nonidet P-40 and 1 mM
EDTA. The beads were washed extensively and boiled in SDS loading
buffer. The proteins were then analyzed by SDS-PAGE and Western
blotting. GST fusion proteins were visualized with colloidal Coomassie
Brilliant Blue G-250.
Luciferase assay
Transfections of 293T and HeLa cells were carried out by using the
PEI (Sigma) (Durocher et al., 2002) and the following DNA constructs:
BFV pLTR-luc, pCMV-BTas, pCMV-BTas (Δ46–62aa) or pcDNA3.1 (+),
with pCMV β-gal as the control for transfection efﬁciency. Cells were
harvested 48 h after transfection, and luciferase assays (Promega)
were performed. Transfection efﬁciency was assessed by determining
β-galactosidase activity, and luciferase activities were normalized byβ-galactosidase activities. Total amounts of DNA were equilibrated by
adding parent plasmids. All transfections were performed in triplicate.
Subcellular localization
HeLa cells were grown on coverslips and transfected 24 h later
with pCMV-BTas or pCMV-BTas (Δ46–62aa). After 48 h, cells were
ﬁxed in 4% paraformaldehyde and permeabilized with 0.2% Triton X-
100. Indirect immunoﬂuorescence was carried out with anti-BTas
antibody and FITC-conjugated rabbit anti-mouse (DAKO) secondary
antibody. Nuclei of the cells were stained with 4,6-diamidino-2-
phenylindole (DAPI). Fluorescence was observed with an Olympus
ﬂuorescence microscope.
Cross-linking assay
293T cells were cultured and transfected with pCMV-Tag2B-BTas,
pCMV-Tag2B-BTas (Δ46–62aa) or pCMV-Tag2B. Forty-eight hours
later, cells were washed with ice-cold PBS and lysed in cross-linking
lysis buffer (20mM Tris–Cl, pH 7.5, 150mM EDTA, 0.5 mMNa3VO4 and
1% NP-40) supplemented with protease inhibitors. The lysates were
sonicated brieﬂy and centrifuged at 15,000 g for 10 min at 4 °C. The
supernatant was mixed with cross-linking buffer (0.01% glutaralde-
hyde in 50 mM triethanolamine, pH 8.2 and 100 mM NaCl) and
incubated at room temperature for 30 min. Cross-linking reactionwas
stopped by addition of SDS-PAGE loading buffer and proteins were
electrophoretically separated by 12% SDS-PAGE followed by immuno-
blotting with an anti-Flag antibody.
Electrophoretic mobility shift assay (EMSA)
The probes used for EMSA included the LTR.TRE and the IP.TRE. The
oligodeoxynucleotides were synthesized, annealed, and digitonin-
labeled using the DIG Gel Shift Kit (Roche). GST fusion proteins (GST-
BTas, and GST-BTas (Δ46–62aa)) were expressed in Escherichia coli
strain BL21 and subsequently puriﬁed by glutathione sepharose beads
(Amersham Biosciences) with PreScisssion Protease according to the
manufacturer's instruction. Protein concentrations were determined
by Bradford assay. The binding reaction was carried out with 2 μg
puriﬁed protein. For competition experiments, unlabeled competitor
oligodeoxynucleotides were added in 20-fold molar excess at the
preincubation period. BFV LTR.TRE sense: 5′-ATAGCTATTTTAGTAAGT-
TAGC-3′. BFV IP.TRE sense: 5′-AGAGCTTAAA AATCAAGGTAAC-3′.
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